Straus Farber, R., Walker, E. L., Diallo, F., Onomichi, K., Riley, C., Zhang, L., Zhu, W., De Jager, P. L., & Xia, Z. (2024). A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Multiple Sclerosis and Related Disorders, 89, 105762. https://doi.org/10.1016/j.msard.2024.105762

Leavitt, V. M., Bae, C., Shinohara, R. T., Weinstein, S. M., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2024). Diagnosis concealment behaviors and disclosure beliefs are associated with health and quality of life in people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105628. https://doi.org/10.1016/j.msard.2024.105628

Holtzer, R., Motl, R. W., Wagshul, M. E., Picone, M. A., Hernandez, M. E., Izzetoglu, M., Lipton, M. L., & Foley, F. W. (2024). Life space assessment and falls in older adults with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105671. https://doi.org/10.1016/j.msard.2024.105671

Leavitt, V. M., Dworkin, J. D., Kalina, T., & Ratzan, A. S. (2024). Sex differences in brain resilience of individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105646. https://doi.org/10.1016/j.msard.2024.105646

Leavitt, V. M., Dworkin, J. D., Galioto, R., & Ratzan, A. S. (2024). Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders, 85, 105508. https://doi.org/10.1016/j.msard.2024.105508

Motl, R. W., Foley, F. W., Picone, M. A., Lipton, M. L., Izzetoglu, M., Hernandez, M. E., & Holtzer, R. (2024). Initial validation of the university of Alabama Birmingham study of aging life-space assessment in older adults with multiple sclerosis. Multiple Sclerosis and Related Disorders, 82, 105354. https://doi.org/10.1016/j.msard.2023.105354

Petracca, M., Palladino, R., Droby, A., Kurz, D., Graziano, N., Wang, K., Riley, C., Howard, J., Klineova, S., Lublin, F., & Inglese, M. (2023). Disability outcomes in early-stage African American and White people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 69, 104413. https://doi.org/10.1016/j.msard.2022.104413

Buyukturkoglu, K., Dworkin, J. D., Leiva, V., Provenzano, F. A., Guevara, P., De Jager, P. L., Leavitt, V. M., & Riley, C. S. (2022). Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis. Multiple Sclerosis and Related Disorders, 68, 104247. https://doi.org/10.1016/j.msard.2022.104247

Leavitt, V. M., Kever, A. M., Weinstein, S. M., Shinohara, R. T., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2022). Diagnosis concealment is prevalent in MS, and associated with diagnosis experience. Multiple Sclerosis and Related Disorders, 68, 104373. https://doi.org/10.1016/j.msard.2022.104373

Boorgu, D. S. S. K., Venkatesh, S., Lakhani, C. M., Walker, E., Aguerre, I. M., Riley, C., Patel, C. J., De Jager, P. L., & Xia, Z. (2022). The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders, 65, 103994. https://doi.org/10.1016/j.msard.2022.103994

Kever, A., Walker, E. L. S., Riley, C. S., Heyman, R. A., Xia, Z., & Leavitt, V. M. (2022). Association of personality traits with physical function, cognition, and mood in multiple sclerosis. Multiple Sclerosis and Related Disorders, 59, 103648. https://doi.org/10.1016/j.msard.2022.103648

Epstein, S., Xia, Z., Lee, A. J., Dahl, M., Edwards, K., Levit, E., Longbrake, E. E., Perrone, C., Kavak, K., Weinstock-Guttman, B., Diallo, F., Ricci, A., Riley, C. S., De Jager, P. L., Farber, R., & Wesley, S. F. (2022). Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. Multiple Sclerosis and Related Disorders, 57, 103433. https://doi.org/10.1016/j.msard.2021.103433